Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis

Development

Volumn 136, Issue 19, 2009, Pages 3347-3356

  Jin, Nili ^a   Cho, Sung Nam ^a   Raso, M Gabriela ^b   Wistuba, Ignacio ^b   Smith, Yvonne ^c   Yang, Yanan ^b   Kurie, Jonathan M ^b   Yen, Rudolph ^b   Evans, Christopher M ^d   Ludwig, Thomas ^e   Jeong, Jae Wook ^a   DeMayo, Francesco J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

EGF signaling; Gene ablation; Lung development; Mitogen inducible gene 6 (Mig 6); Vascularization

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN INDUCIBLE PROTEIN 6; PROTEIN KINASE B; UNCLASSIFIED DRUG; MIG 6 PROTEIN, HUMAN; MIG-6 PROTEIN, HUMAN; MIG6 PROTEIN, MOUSE; PRIMER DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; HOMEOSTASIS; LETHALITY; LUNG DEVELOPMENT; MOUSE; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BRONCHIOLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LUNG; METABOLISM; MOUSE MUTANT; NEWBORN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; RNA INTERFERENCE;

MUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BASE SEQUENCE; BRONCHIOLES; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEOSTASIS; HUMANS; LUNG; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 70349923552     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.032979     Document Type: Article

References (67)

1. Amatschek, S., Koenig, U., Auer, H., Steinlein, P., Pacher, M., Gruenfelder, A., Dekan, G., Vogl, S., Kubista, E., Heider, K. H. et al. (2004). Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 64, 844-856.
2. Anastasi, S., Fiorentino, L., Fiorini, M., Fraioli, R., Sala, G., Castellani, L., Alema, S., Alimandi, M. and Segatto, O. (2003). Feedback inhibition by RALT controls signal output by the ErbB network. Oncogene 22, 4221-4234.
3. Anastasi, S., Sala, G., Huiping, C., Caprini, E., Russo, G., Iacovelli, S., Lucini, F., Ingvarsson, S. and Segatto, O. (2005). Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 24, 4540-4548.
4. Augustin, H. G., Koh, G. Y., Thurston, G. and Alitalo, K. (2009). Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165-177.
5. Ballaro, C., Ceccarelli, S., Tiveron, C., Tatangelo, L., Salvatore, A. M., Segatto, O. and Alema, S. (2005). Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype. EMBO Rep. 6, 755-761.
6. Bhandari, A. and Panitch, H. B. (2006). Pulmonary outcomes in bronchopulmonary dysplasia. Semin. Perinatol. 30, 219-226.
7. Bhatt, A. J., Pryhuber, G. S., Huyck, H., Watkins, R. H., Metlay, L. A. and Maniscalco, W. M. (2001). Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 164, 1971-1980.
8. Bry, K., Whitsett, J. A. and Lappalainen, U. (2007). IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am. J. Respir. Cell Mol. Biol. 36, 32-42.
9. Chess, P. R., Ryan, R. M. and Finkelstein, J. N. (1998). H441 pulmonary epithelial cell mitogenic effects and signaling pathways in response to HGF and TGF-alpha. Exp. Lung Res. 24, 27-39.
10. Chu, D. T., Davis, C. M., Chrapkiewicz, N. B. and Granner, D. K. (1988). Reciprocal regulation of gene transcription by insulin. Inhibition of the phosphoenolpyruvate carboxykinase gene and stimulation of gene 33 in a single cell type. J. Biol. Chem. 263, 13007-13011.
11. Coalson, J. J. (2003). Pathology of new bronchopulmonary dysplasia. Semin. Neonatol. 8, 73-81.
12. Copland, I. B. and Post, M. (2007). Stretch-activated signaling pathways responsible for early response gene expression in fetal lung epithelial cells. J. Cell. Physiol. 210, 133-143.
13. Costa, R. H., Kalinichenko, V. V. and Lim, L. (2001). Transcription factors in mouse lung development and function. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L823-L838.
14. Dave, V., Wert, S. E., Tanner, T., Thitoff, A. R., Loudy, D. E. and Whitsett, J. A. (2007). Conditional deletion of Pten causes bronchiolar hyperplasia. Am. J. Respir. Cell Mol. Biol. 38, 337-345.
15. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C. et al. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
16. DeLisser, H. M., Helmke, B. P., Cao, G., Egan, P. M., Taichman, D., Fehrenbach, M., Zaman, A., Cui, Z., Mohan, G. S., Baldwin, H. S. et al. (2006). Loss of PECAM-1 function impairs alveolarization. J. Biol. Chem. 281, 8724-8731.
17. de Luca, C., Kowalski, T. J., Zhang, Y., Elmquist, J. K., Lee, C., Kilimann, M. W., Ludwig, T., Liu, S. M. and Chua, S. C., Jr (2005). Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115, 3484-3493.
18. Ding, W., Shi, W., Bellusci, S., Groffen, J., Heisterkamp, N., Minoo, P. and Warburton, D. (2007). Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. J. Cell. Physiol. 212, 796-806.
19. Ferby, I., Reschke, M., Kudlacek, O., Knyazev, P., Pante, G., Amann, K., Sommergruber, W., Kraut, N., Ullrich, A., Fassler, R. et al. (2006). Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat. Med. 12, 568-573.
20. Fiorentino, L., Pertica, C., Fiorini, M., Talora, C., Crescenzi, M., Castellani, L., Alema, S., Benedetti, P. and Segatto, O. (2000). Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol. Cell. Biol. 20, 7735-7750.
21. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T. and Gillespie, G. Y. (1993). Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 4, 121-133.
22. Hackel, P. O., Gishizky, M. and Ullrich, A. (2001). Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol. Chem. 382, 1649-1662.
23. Inselman, L. S. and Mellins, R. B. (1981). Growth and development of the lung. J. Pediatr. 98, 1-15.
24. Jeong, J. W., Lee, H. S., Lee, K. Y., White, L. D., Broaddus, R. R., Zhang, Y. W., Vande Woude, G. F., Giudice, L. C., Young, S. L., Lessey, B. A. et al. (2009). Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease. Proc. Natl. Acad. Sci. USA 106, 8677-8682.
25. Jin, N., Gilbert, J. L., Broaddus, R. R., Demayo, F. J. and Jeong, J. W. (2007). Generation of a Mig-6 conditional null allele. Genesis 45, 716-721.
26. Kent, T. A., Messina, J. L., Weinstock, R. S. and Stein, J. P. (1994). Synergistic induction of gene 33 expression by retinoic acid and insulin. Endocrinology 134, 2237-2244.
27. Kling, D. E., Brandon, K. L., Sollinger, C. A., Cavicchio, A. J., Ge, Q., Kinane, T. B., Donahoe, P. K. and Schnitzer, J. J. (2006). Distribution of ERK1/2 and ERK3 during normal rat fetal lung development. Anat. Embryol. (Berl.) 211, 139-153.
28. Korfhagen, T. R., Swantz, R. J., Wert, S. E., McCarty, J. M., Kerlakian, C. B., Glasser, S. W. and Whitsett, J. A. (1994). Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J. Clin. Invest. 93, 1691-1699.
29. Kramer, E. L., Deutsch, G. H., Sartor, M. A., Hardie, W. D., Ikegami, M., Korfhagen, T. R. and Le Cras, T. D. (2007). Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L314-L327.
30. Lassus, P., Turanlahti, M., Heikkila, P., Andersson, L. C., Nupponen, I., Sarnesto, A. and Andersson, S. (2001). Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am. J. Respir. Crit. Care Med. 164, 1981-1987.
31. Le Cras, T. D., Hardie, W. D., Fagan, K., Whitsett, J. A. and Korfhagen, T. R. (2003). Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1046-L1054.
32. Le Cras, T. D., Hardie, W. D., Deutsch, G. H., Albertine, K. H., Ikegami, M., Whitsett, J. A. and Korfhagen, T. R. (2004). Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L718-L729.
33. Lee, K. L., Isham, K. R., Stringfellow, L., Rothrock, R. and Kenney, F. T. (1985). Molecular cloning of cDNAs cognate to genes sensitive to hormonal control in rat liver. J. Biol. Chem. 260, 16433-16438.
34. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
35. Makkinje, A., Quinn, D. A., Chen, A., Cadilla, C. L., Force, T., Bonventre, J. V. and Kyriakis, J. M. (2000). Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress. J. Biol. Chem. 275, 17838-17847.
36. Maniscalco, W. M., Watkins, R. H., Pryhuber, G. S., Bhatt, A., Shea, C. and Huyck, H. (2002). Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am. J. Physiol. Lung Cell Mol. Physiol. 282, L811-L823.
37. Miettinen, P. J., Warburton, D., Bu, D., Zhao, J. S., Berger, J. E., Minoo, P., Koivisto, T., Allen, L., Dobbs, L., Werb, Z. et al. (1997). Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 186, 224-236.
38. Pante, G., Thompson, J., Lamballe, F., Iwata, T., Ferby, I., Barr, F. A., Davies, A. M., Maina, F. and Klein, R. (2005). Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth. J. Cell Biol. 171, 337-348.
39. Pardanaud, L. and Dieterlen-Lievre, F. (1999). Manipulation of the angiopoietic/hemangiopoietic commitment in the avian embryo. Development 126, 617-627.
40. Perl, A. K. and Whitsett, J. A. (1999). Molecular mechanisms controlling lung morphogenesis. Clin. Genet. 56, 14-27.
41. Salomon, D. S., Brandt, R., Ciardiello, F. and Normanno, N. (1995). Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 19, 183-232.
42. Schwarz, M. A., Zhang, F., Gebb, S., Starnes, V. and Warburton, D. (2000). Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis. Mech. Dev. 95, 123-132.
43. Shi, W., Bellusci, S. and Warburton, D. (2007). Lung development and adult lung diseases. Chest 132, 651-656.
44. Shibuya, M. (2008). Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep. 41, 278-286.
45. Sibilia, M. and Wagner, E. F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238.
46. Singh, A. B. and Harris, R. C. (2005). Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal. 17, 1183-1193.
47. Stahlman, M. T., Orth, D. N. and Gray, M. E. (1989). Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab. Invest. 60, 539-547.
48. Strandjord, T. P., Clark, J. G., Guralnick, D. E. and Madtes, D. K. (1995). Immunolocalization of transforming growth factor-alpha, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung. Pediatr. Res. 38, 851-856.
49. Stratmann, A., Risau, W. and Plate, K. H. (1998). Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459-1466.
50. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
51. Tseng, R. C., Chang, J. W., Hsien, F. J., Chang, Y. H., Hsiao, C. F., Chen, J. T., Chen, C. Y., Jou, Y. S. and Wang, Y. C. (2005). Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int. J. Cancer 117, 241-247.
52. Uzumcu, M., Westfall, S. D., Dirks, K. A. and Skinner, M. K. (2002). Embryonic testis cord formation and mesonephric cell migration requires the phosphotidylinositol 3-kinase signaling pathway. Biol. Reprod. 67, 1927-1935.
53. Wang, J., Ito, T., Udaka, N., Okudela, K., Yazawa, T. and Kitamura, H. (2005). PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung. Tissue Cell 37, 25-35.
54. Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D. and Cardoso, W. V. (2000). The molecular basis of lung morphogenesis. Mech. Dev. 92, 55-81.
55. Warburton, D., Tefft, D., Mailleux, A., Bellusci, S., Thiery, J. P., Zhao, J., Buckley, S., Shi, W. and Driscoll, B. (2001). Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? Am. J. Respir. Crit. Care Med. 164, S59-S62.
56. Wick, M., Burger, C., Funk, M. and Muller, R. (1995). Identification of a novel mitogen-inducible gene (mig-6): regulation during G1 progression and differentiation. Exp. Cell Res. 219, 527-535.
57. Xing, H., Zhang, S., Weinheimer, C., Kovacs, A. and Muslin, A. J. (2000). 14- 3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19, 349-358.
58. Xu, D., Makkinje, A. and Kyriakis, J. M. (2005). Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J. Biol. Chem. 280, 2924-2933.
59. Xu, D., Patten, R. D., Force, T. and Kyriakis, J. M. (2006). Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling. Mol. Cell. Biol. 26, 5043-5054.
60. Xu, J., Keeton, A. B., Wu, L., Franklin, J. L., Cao, X. and Messina, J. L. (2005). Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression. Breast Cancer Res. Treat. 91, 207-215.
61. Yamamoto, H., Yun, E. J., Gerber, H. P., Ferrara, N., Whitsett, J. A. and Vu, T. H. (2007). Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev. Biol. 308, 44-53.
62. Yanagi, S., Kishimoto, H., Kawahara, K., Sasaki, T., Sasaki, M., Nishio, M., Yajima, N., Hamada, K., Horie, Y., Kubo, H. et al. (2007). Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J. Clin. Invest. 117, 2929-2940.
63. Zeng, X., Wert, S. E., Federici, R., Peters, K. G. and Whitsett, J. A. (1998). VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev. Dyn. 211, 215-227.
64. Zhang, S., Ren, J., Zhang, C. E., Treskov, I., Wang, Y. and Muslin, A. J. (2003). Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ. Res. 93, 1026-1028.
65. Zhang, Y. W. and Vande Woude, G. F. (2007). Mig-6, signal transduction, stress response and cancer. Cell Cycle 6, 507-513.
66. Zhang, Y. W., Su, Y., Lanning, N., Swiatek, P. J., Bronson, R. T., Sigler, R., Martin, R. W. and Vande Woude, G. F. (2005). Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. Proc. Natl. Acad. Sci. USA 102, 11740-11745.
67. Zhang, Y. W., Staal, B., Su, Y., Swiatek, P., Zhao, P., Cao, B., Resau, J., Sigler, R., Bronson, R. and Vande Woude, G. F. (2007). Evidence that MIG-6 is a tumor-suppressor gene. Oncogene 26, 269-276.